# Naltrexone Treatment for Prolonged Grief Disorder (PGD)

> **NCT04547985** · PHASE4 · TERMINATED · sponsor: **Weill Medical College of Cornell University** · enrollment: 9 (actual)

## Conditions studied

- Prolonged Grief Disorder

## Interventions

- **DRUG:** Naltrexone HCl 50 MG Oral Tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04547985
- **Lead sponsor:** Weill Medical College of Cornell University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-01-05
- **Primary completion:** 2023-10-16
- **Final completion:** 2023-10-16
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** We are terminating the study due to low accrual.
- **Last updated:** 2024-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04547985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04547985, "Naltrexone Treatment for Prolonged Grief Disorder (PGD)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04547985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*